Compagnie Industriali Riunite S.p.A.

Equities

CIR

IT0000080447

Delayed Borsa Italiana Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-47.70%	-45.68%

Apr. 22	CIR bought back own shares for EUR609,000 approx.	AN
Apr. 15	CIR goes ahead with buybacks of its own ordinary shares	AN

CIR in first half sees revenues and profit on the rise

July 31, 2023 at 08:08 am EDT

(Alliance News) - CIR Spa announced Monday that it has seen results for the first half of the year, in which it reported consolidated revenues of EUR1.22 billion, up 12 percent from the first half of 2022, with positive dynamics in both business sectors of the group.

Consolidated Ebitda amounted to EUR170.0 million, up 15 percent compared to the corresponding period in 2022, thanks to growth in revenues and profitability in both sectors in which the group operates.

Net income was EUR14.0 million compared to a break-even result in the first half of 2022.

Net financial position of the parent company was EUR314.0 million; the slight decrease compared to December 31, 2022, EUR320.4 million, is due to the purchase of treasury shares for EUR7.7 million during the period.

CIR's board of directors appointed Antonio Segni, a partner at Studio Gianni & Origoni, as new board secretary, replacing Pietro La Placa, general counsel and secretary of CIR's board of directors, who has decided to embark on a new professional project.

CIR trades in the green by 1.6 percent at EUR0.41 per share.

By Claudia Cavaliere, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Go to the original article.
Legal disclaimer

Latest news about Compagnie Industriali Riunite S.p.A.

CIR bought back own shares for EUR609,000 approx.	Apr. 22	AN
CIR goes ahead with buybacks of its own ordinary shares	Apr. 15	AN
CIR buys back own ordinary shares for over EUR160,000	Apr. 08	AN
CIR goes ahead with buybacks of its own ordinary shares	Apr. 03	AN
CIR goes ahead with buybacks of its own ordinary shares	Mar. 29	AN
CIR has purchased treasury shares for more than EUR610,000	Mar. 25	AN
BlackRock and Capital Fund exceed 0.5 percent on TIM	Mar. 21	AN
CIR purchases 1.9 million of its own ordinary shares	Mar. 18	AN
CIR goes ahead with buybacks as part of its buyback plan	Mar. 11	AN
CIR returns to profit and improves indicators in 2023	Mar. 11	AN
CIR goes ahead with buybacks with substantial share buyback	Mar. 04	AN
CIR has purchased more than one million of its own shares	Feb. 26	AN
Sogefi soars after accounts and Filtration deal	Feb. 26	AN
Marshall Wace cuts short on Saipem	Feb. 23	AN
CIR has purchased more than 820,000 of its own ordinary shares	Feb. 20	AN
Futures on "sell" side; UK inflation stable	Feb. 14	AN
Mib bearish in 31,100 area; Saipem stays afloat	Feb. 13	AN
CIR has purchased nearly 600,000 of its own ordinary shares	Feb. 12	AN
CIR goes ahead with its share buyback program	Feb. 05	AN
CIR ahead with buybacks, bought back own shares for over EUR100,000	Jan. 30	AN
CIR has purchased more than 521,000 of its own ordinary shares	Jan. 22	AN
CIR goes ahead with its share buyback program	Jan. 15	AN
CIR continues with buybacks of its own ordinary shares	Jan. 09	AN
CIR goes ahead with its share buyback program	Jan. 04	AN
CIR continues purchases as part of buyback program	Dec. 27	AN

Chart Compagnie Industriali Riunite S.p.A.

Duration

Period

Chart Compagnie Industriali Riunite S.p.A.

More charts

Company Profile

CIR SpA Compagnie Industriali Riunite is an Italy-based company. The Company structures its business into five sectors: Energy, Media, Automotive Components, Healthcare and Non-core Investments. In the Energy sector, the Company is active in the generation of electrical power and distribution of natural gas. The Media sector is focused on publishing, radio, television and Internet portals operation. The Automotive Components sector is primarily engaged in the production of engine systems and suspension components. In the Healthcare sector, the Company is active in the operation of nursing homes and rehabilitation centers, as well as in the provision of hi-tech medical services, such as diagnostic imagining, nuclear medicine and radio therapy. In the Non-core Investments sector, the Company is involved in venture capital funds, private equity funds and other investments.

Sector

More about the company